An illustration photo shows boxes of Tylenol in Schwenksville, Pennsylvania, U.S. September 24, 2025. REUTERS/Hannah Beier/File Photo A Texas judge cleared the way for Kenvue to pay a $398 million ...
Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus erythematosus (SLE) have been revealed, and have not disappointed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback